| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |